Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

Innovation Presentations from Merck, Amgen, Harvest Moon Pharmaceuticals, Lupin ltd at Biosimilars & Biobetters 2014

publication date: Aug 18, 2014
 | 
author/source: SMi Group

SMi Group reports: Biosimilars & Biobetters Conference will taking place in London on 29th & 30th September 2014. 3-day event, over 16 innovative presentations, 2 half-day workshops, hours of networking

SMi group logoBuilding unto the success of last year, Biosimilars & Biobetters 2014 will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market. 

The agenda aims to bring together pharma, biotech and legal experts explaining the advantages and disadvantages within this growing market, looking at case studies from those who are developing and distributing follow on biologics with analysis of key trends in biologic pipelines, latest thinking and techniques in this growing area.

16 speakers from leading organisations will deliver innovative case-studies and presentations to include Harvest Moon Pharmaceuticals, Medimmune (AstraZeneca Biologics), Amgen, Lupin Ltd, Merck, IMS Health (UK), Fresenius Kabi Headquarters and more. Two workshops, delivered by Fresenius Kabi Headquarters and PanGenerika will also provide a detailed overview of the current regulatory situation and profitability of biosimilars and biobetters.

Keynote speakers include Catherine Akers, Regulatory Affairs Manager, Amgen, presenting on: Pharmacovigilance considerations for biologics and biosimilars, and Dr. Uwe Gudat, Head of Safety Biosimilars, Merck, who will speak on: A clinical perspective on biosimilars: development and beyond.

Latest registered attendees include: Boehringer Ingelheim, Merck Switzerland, Sanofi-Aventis SA, AbbVie, Europe Bioproducts, Takeda UK, University of Basel, Esteve SA, BD Biosciences, Univercelles plus many more  

Sponsored by Europa Bioproducts and Schwegman, Lundberg & Woessner.


more about SMi group


more about the full conference programme



If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners